- The House of Representatives and the Senate are on District / State work periods through Labor Day, September 1, 2025.
- Roll Call adds,
- “President Donald Trump gave Senate Republicans permission to begin their August recess Saturday night [August 2, 2025], shortly before Democratic and Republican leaders agreed to quickly vote on seven final civilian nominees but none of the more than 100 still pending on the calendar.
- “The agreement allowed for votes to begin on cloture and confirmation of the nominees without debate. Among those confirmed under the deal was Jeanine Pirro, who was nominated by Trump to be U.S. attorney for the District of Columbia.
- “The directive from Trump took pressure off of Senate Majority Leader John Thune, R-S.D., to clear the executive calendar and confirm all of Trump’s pending nominees before the recess.”
- The Wall Street Journal reports,
- “The Senate late Friday [August 1, 2025,] passed more than $180 billion in funding for veterans programs, new military facilities, the Agriculture Department and the Food and Drug Administration, as lawmakers moved to reassert their control over federal spending amid challenges from the Trump administration.
- “The Senate approved the bulk of the spending in a 87-9 vote. It separately cleared a measure funding Congress’s own operations as well as related entities that audit federal spending and evaluate the budgetary implications of federal laws. The legislation must go back to the House, which is on recess and will return for legislative business in September.
- “We are on the verge of an accomplishment that we have not done since 2018, and that is, pass appropriations bills across the Senate floor prior to the August recess,” Senate Appropriations Committee Chair Susan Collins (R., Maine) said shortly before the measures passed. “That is exercising our constitutional responsibility for the power of the purse.”
- “Sen. Patty Murray (D., Wash.), the top Democrat on the panel, said, “I believe Congress should decide how to spend taxpayer dollars. This is how we do it.”
From the public health and medical research front,
- The Wall Street Journal points out,
- “Falls are the leading cause of injury for people 65 and older, but the factors that lead to falls can start much earlier.
- “The risk of falling in a given year doubles with every additional related issue—including reduced muscle strength, balance problems, medication side effects and even forgetting to take that medicine—according to a recent research paper.
- “That’s why medical experts say that, beginning at age 65, everyone should have an initial screening to determine their personal risk level.
- “Many people think only frail older people in nursing homes fall. But even the youngerold—those who are healthy and active—can fall,” says Emily Nabors, associate director of innovation at the National Council on Aging.
- “The nonprofit offers a short online questionnaire that provides a fall-risk score, but Nabors suggests people also get a more comprehensive assessment from a doctor or physical therapist.
- “Even if you’re at low risk now, there are things you can do to stay that way. And they go beyond removing trip hazards in your home.”
- The Washington Post lets us know,
- “Shortly after finishing breakfast six years ago, Brian Farrington felt some discomfort and thought it was heartburn. He popped a few Tums but hours later began perspiring profusely and experiencing chest pain.
- “The next morning, Farrington, who was 53 and seemingly healthy, headed to the hospital and was shocked to learn he had suffered a heart attack. He had several blockages in his right artery. Previously, Farrington had been told his cholesterol was “borderline high” but did not require medication.
- “As the resident of Columbus, Ohio, recovered, he considered a nagging question: Why was there so much premature heart disease in his family? His grandfather and three great-uncles had died of heart disease in their 40s, and his father had gotten a stent in his 60s. He decided to dig deeper.
- “Farrington eventually discovered he had a heart threat that he — and many other people — had never even heard of: High levels of a fatty particle called Lipoprotein(a). The molecule is similar to LDL, the “bad” cholesterol that circulates in the blood and can promote coronary plaque, increasing the risk of heart attacks.
- “But Lp(a) carries an extra protein that makes it an even bigger cardiac risk factor than LDL, studies have shown. Higher-than-normal levels encourage the development of blood clots as well as plaque, sharply raising the risk of stroke, heart attack and other severe problems — even among younger people with normal levels of LDL, doctors say.“
- and
- “In March 2024, radiation oncologist Sanjay Mehta had been dealing with painful Achilles tendinitis on his left ankle for over a year. He’d tried steroid injections and PRP (platelet-rich plasma) injections, which Mehta said eventually did the trick.
- “But when his right Achilles started hurting three months later, he opted for a different approach. He had recently started offering low-dose radiation therapy to treat some patients suffering from inflammatory conditions and thought: Why not try it himself? After six self-administered low-dose X-rays, covered by insurance, he found he was pain-free — and he began offering the therapy to more patients with similar noncancerous conditions.
- “The main surprise was … why didn’t I think of this earlier?” he said.
- “Mehta is part of a growing trend among U.S. radiation specialists, who have begun offering low-dose X-ray therapy for benign conditions such as arthritis, plantar fasciitis, Peyronie’s disease and thick raised scars, or keloids.
- “After the American Society for Radiation Oncology discussed the use of low-dose radiation therapy for nonmalignant conditions in its spring 2024 quarterly newsletter, its use began to pick up steam, Mehta said. Unlike radiation therapy for cancer, LDRT, as its name suggests, uses low doses to suppress inflammatory cells. Mehta said six LDRT treatments expose the patient to about the same amount of radiation as in one cancer treatment or what someone might get from “a few” CT scans.”
- The New York Times tells us that “‘Japanese Walking’ Is a fitness trend worth trying. The workout is simple, and its health benefits are backed by nearly 20 years of research. Check it out.
- Per MedPage Today,
- “An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer’s disease, researchers said here.
- “Continued lecanemab treatment with 360 mg subcutaneous dosing resulted in a similar additional reduction of amyloid PET over 4 years of treatment as continuing biweekly IV lecanemab, reported Larisa Reyderman, PhD, of drugmaker Eisai, at the Alzheimer’s Association International Conference (AAIC).
